CRWD · NASDAQ-GS
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $4.81B | $3.95B | $3.06B | $2.24B | $1.45B | $874.44M | $481.41M | $249.82M |
| Cost of Revenue | $1.22B | $990.17M | $758.93M | $601.23M | $383.22M | $229.54M | $141.63M | $87.24M |
| Gross Profit | $3.59B | $2.96B | $2.30B | $1.64B | $1.07B | $644.89M | $339.79M | $162.59M |
| Research & Development | $1.38B | $1.08B | $780.32M | $608.36M | $371.28M | $214.67M | $130.19M | $84.55M |
| Selling, General & Administrative | $670.34M | $481.26M | $395.17M | $317.34M | $223.09M | $121.44M | $89.07M | $42.22M |
| Operating Expenses | $3.89B | $3.08B | $2.32B | $1.83B | $1.21B | $737.42M | $485.85M | $299.45M |
| Operating Income | -$293.29M | -$116.40M | -$19.14M | -$190.11M | -$142.55M | -$92.53M | -$146.06M | -$136.86M |
| Interest Expense | — | — | $25.76M | $25.32M | $25.23M | $1.56M | $442.00K | $428.00K |
| Other Income / (Expense) | -$645.00K | $5.10M | $1.64M | $3.05M | $3.97M | $1.25M | $6.72M | -$1.42M |
| Income Before Taxes | -$126.99M | $58.56M | $105.67M | -$159.88M | -$160.02M | -$87.87M | -$139.78M | -$138.71M |
| Provision for Income Taxes | $34.18M | $71.13M | $32.23M | $22.40M | $72.36M | $4.76M | $2.00M | $1.37M |
| Net Income | -$161.16M | -$12.57M | $73.44M | -$182.28M | -$232.38M | -$92.63M | -$141.78M | -$140.08M |
| Basic EPS | -$0.65 | -$0.06 | $0.30 | -$0.79 | -$1.03 | -$0.43 | -$0.96 | — |
| Diluted EPS | -$0.65 | -$0.06 | $0.30 | -$0.79 | -$1.03 | -$0.43 | -$0.96 | — |
| Basic Shares Outstanding | 250.58M | 244.75M | 238.64M | 233.14M | 227.14M | 217.76M | 148.06M | — |
| Diluted Shares Outstanding | 250.58M | 244.75M | 243.63M | 233.14M | 227.14M | 217.76M | 148.06M | — |
| Period | Consensus EPS | Low | High | Estimates | Revisions |
|---|---|---|---|---|---|
| Jan 2027 | $0.23 | $0.17 | $0.31 | 16 | ↑0 ↓11 |
| Jan 2028 | $0.41 | $0.29 | $0.81 | 15 | ↑3 ↓6 |
| Jan 2029 | $0.66 | $0.45 | $0.99 | 3 | ↑1 ↓0 |